Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.47 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.45 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.45 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6464181 | 0.87 | HCRTR1 (0.62) | HCRTR1KMT2AMEN1L3MBTL1MAPT | |
| SCHEMBL10324240 | 0.84 | HCRTR1 (0.55) | HCRTR1KMT2AMEN1L3MBTL1MAPT | |
| SCHEMBL27461383 | 0.81 | ALDH1A1 (0.70) | HCRTR1KMT2AMEN1L3MBTL1MAPT | |
| SCHEMBL7628280 | 0.81 | HCRTR1 (0.55) | HCRTR1KMT2AMEN1L3MBTL1MAPT | |
| SCHEMBL7634707 | 0.81 | HCRTR1 (0.55) | HCRTR1KMT2AMEN1L3MBTL1MAPT | |
| SCHEMBL7629518 | 0.81 | HCRTR1 (0.49) | HCRTR1KMT2AMEN1L3MBTL1MAPT | |
| SCHEMBL28992535 | 0.80 | HCRTR1 (0.62) | HCRTR1KMT2AMEN1L3MBTL1MAPT | |
| SCHEMBL4282830 | 0.80 | HCRTR1 (0.62) | HCRTR1KMT2AMEN1L3MBTL1MAPT | |
| SCHEMBL7627703 | 0.79 | HCRTR1 (0.54) | HCRTR1KMT2AMEN1L3MBTL1MAPT | |
| SCHEMBL15972632 | 0.79 | ALDH1A1 (0.47) | KMT2AL3MBTL1LMNAALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| EP-4237396-B1 | METHOD OF MITIGATING CONVERSION OF VOLATILE TERPENE SPECIES | GIVAUDAN SA (CH) | 2026-02-18 | — | — | EP | disclosed |
| US-20260027132-A1 | FRAGRANCE COMPOSITIONS AND USE THEREOF FOR IMPROVING SLEEP | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2026-01-29 | — | — | US | disclosed |
| EP-4237393-B1 | METHOD OF CAUSING CONVERSION OF VOLATILE TERPENE SPECIES | GIVAUDAN SA (CH) | 2025-12-24 | — | — | EP | disclosed |
| US-20250333368-A1 | METHOD OF MITIGATING CONVERSION OF VOLATILE TERPENE SPECIES | GIVAUDAN SA (CH) | 2025-10-30 | — | — | US | disclosed |
| US-12453736-B2 | Fragrance compositions and use thereof for improving sleep | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2025-10-28 | — | — | US | disclosed |
| EP-3164107-B1 | LACTONE-CONTAINING COMPOSITIONS FOR MALODOR ELIMINATION | TAKASAGO PERFUMERY CO LTD (JP) | 2025-09-03 | — | — | EP | disclosed |
| US-12351546-B2 | Method of mitigating conversion of volatile terpene species | GIVAUDAN SA (CH) | 2025-07-08 | — | — | US | disclosed |
| US-20250091984-A1 | FRAGRANCE AND FLAVOR MATERIALS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2025-03-20 | — | — | US | disclosed |
| EP-4504693-A1 | FRAGRANCE AND FLAVOR MATERIALS | Takasago International Corporation (JP) | 2025-02-12 | — | — | EP | disclosed |
| WO-2018119469-A1 | FRAGRANCE AND FLAVOR MATERIALS | TAKASAGO INTERNATIONAL CORPORATION (USA) (US) | 2018-06-28 | — | — | WO | disclosed |
| WO-2018119466-A1 | FRAGRANCE AND FLAVOR MATERIALS | TAKASAGO INTERNATIONAL CORPORATION (USA) (US) | 2018-06-28 | — | — | WO | disclosed |
| WO-2018119471-A1 | FRAGRANCE AND FLAVOR MATERIALS | TAKASAGO INTERNATIONAL CORPORATION (USA) (US) | 2018-06-28 | — | — | WO | disclosed |
| WO-2018005839-A1 | FRAGRANCE COMPOSITIONS AND METHODS OF USE THEREOF | TAKASAGO INTERNATIONAL CORPORATION (USA) (US) | 2018-01-04 | — | — | WO | disclosed |
| WO-2018005844-A1 | FRAGRANCE COMPOSITIONS AND METHODS OF USE THEREOF | TAKASAGO INTERNATIONAL CORPORATION (USA) (US) | 2018-01-04 | — | — | WO | disclosed |
| WO-2017214455-A1 | FRAGRANCE MATERIAL | TAKASAGO INTERNATIONAL CORPORATION (USA) (US) | 2017-12-14 | — | — | WO | disclosed |
| WO-2017214446-A1 | FRAGRANCE MATERIAL | TAKASAGO INTERNATIONAL CORPORATION (USA) (US) | 2017-12-14 | — | — | WO | disclosed |
| EP-3164107-A2 | LACTONE-CONTAINING COMPOSITIONS FOR MALODOR ELIMINATION | Takasago International Corporation (JP) | 2017-05-10 | — | — | EP | disclosed |
| WO-2016001761-A2 | LACTONE-CONTAINING COMPOSITIONS FOR MALODOR ELIMINATION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-01-07 | — | — | WO | disclosed |
| US-20160000679-A1 | LACTONE-CONTAINING COMPOSITIONS FOR MALODOR ELIMINATION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250091984-A1 | FRAGRANCE AND FLAVOR MATERIALS | TAS2R5, TAS2R8, NISCH | HCRTR1 3190/4885KMT2A 1621/4885MEN1 2848/4885 |
| US-20160000679-A1 | LACTONE-CONTAINING COMPOSITIONS FOR MALODOR ELIMINATION | LPO, SMOX, ME1 | HCRTR1 2680/4885KMT2A 1744/4885MEN1 1476/4885 |
| US-20260027132-A1 | FRAGRANCE COMPOSITIONS AND USE THEREOF FOR IMPROVING SLEEP | B2M, PER2, CHRM2 | HCRTR1 345/4885KMT2A 2371/4885MEN1 4405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.